US Regulatory Roundup, September 2021: Product Safety, Pediatric Devices, EUAs Revoked, And More

With news of high-risk medical device recalls and troubles with COVID-19 diagnostics, product safety was of paramount concern to Medtech Insight readers in September. Also topping the most-read list were articles focused on pediatric patients, the revocation of emergency use authorizations for products to treat and diagnose COVID-19, and more.

Top Stories US

With news of high-risk medical device recalls and troubles with COVID-19 diagnostics, product safety was of paramount concern to Medtech Insight readers in September, with three safety-related articles landing on our Top 10 list of most-read stories.

In our No. 1 story from last month, we explained how Alinity m SARS-CoV-2 AMP and Alinity m Resp-4-Plex AMP Kits made by Abbott Molecular Inc. may falsely...

More from United States

More from North America